Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Xiaoying Jia, Yang Zhao, Justin Carrico, Thor-Henrik Brodtkorb, Alan M. Mendelsohn, Simon Lowry, Steve Feldman, Jashin J. Wu & April W. Armstrong. (2022) Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States. Journal of Dermatological Treatment 33:2, pages 740-748.
Read now
Read now
Jashin J. Wu, Xiaoying Jia, Yang Zhao, Justin Carrico, Thor-Henrik Brodtkorb, Alan Mendelsohn, Simon Lowry, Steven R. Feldman & April Armstrong. (2021) Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. Journal of Dermatological Treatment 32:7, pages 693-700.
Read now
Read now
Pinar Incel Uysal, Buket Sahin, Basak Yalcin, Afra Alkan & Selcen Yuksel. (2018) Psoriasis management in actual clinical practice: a 6-year retrospective study of 845 patients. Journal of Dermatological Treatment 29:8, pages 797-801.
Read now
Read now
Ricardo Romiti, Lincoln Helder Zambaldi Fabrício, Cacilda da Silva Souza, Leticia Oba Galvão, Caio Cesar Silva de Castro, Aripuanã Cobério Terena, Francisca Regina Oliveira Carneiro, Luiza Keiko Matsuka Oyafuso, Sueli Carneiro, Bernardo Gontijo, Clarice Marie Kobata, Maria de Fátima Paim de Oliveira, Tania Cestari, João Roberto Antônio, Gladys Aires Martins, Silvio Alencar Marques, Sulamita Costa Wirth Chaibub, Ana Carolina Belini Bazán Arruda, Paulo Antonio Oldani Félix, Renata Ferreira Magalhães, Luna Azulay Abulafia, Karine A. Ferreira, Aline Medeiros da Silva, Bruno Leonardo Silva & Juliano Souza. (2018) Assessment of psoriasis severity in Brazilian patients with chronic plaque psoriasis attending outpatient clinics: a multicenter, population-based cross-sectional study (APPISOT). Journal of Dermatological Treatment 29:8, pages 775-785.
Read now
Read now
Joseph S. Aleshaki, Leah A. Cardwell, Mikél E. Muse & Steven R. Feldman. (2018) Adherence and resource use among psoriasis patients treated with biologics. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 609-617.
Read now
Read now
Mwangi J. Murage, Amanda Anderson, Susan A. Oliveria, Deborah Casso, Clement K. Ojeh, Talia M. Muram, Joseph F. Merola & Andre B. Araujo. (2018) Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity. Journal of Medical Economics 21:8, pages 745-754.
Read now
Read now
Sarah Al Sawah, Shonda A. Foster, Orin M. Goldblum, William N. Malatestinic, Baojin Zhu, Nianwen Shi, Xue Song & Steven R. Feldman. (2017) Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis. Journal of Medical Economics 20:9, pages 982-990.
Read now
Read now
Mathias Tiedemann Svendsen, Janithika Jeyabalan, Klaus Ejner Andersen, Flemming Andersen & Helle Johannessen. (2017) Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review. Journal of Dermatological Treatment 28:5, pages 374-383.
Read now
Read now
Steven R Feldman, Chakkarin Burudpakdee, Smeet Gala, Merena Nanavaty & Usha G Mallya. (2014) The economic burden of psoriasis: a systematic literature review. Expert Review of Pharmacoeconomics & Outcomes Research 14:5, pages 685-705.
Read now
Read now
Steven R. Feldman, Eugenia Levi, Prathamesh Pathak, Sonali Kakatkar & Rajesh Balkrishnan. (2013) Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs. Journal of Medical Economics 16:12, pages 1405-1413.
Read now
Read now
Hsien-Chang Lin, Pedro T. Lucas, Steven R. Feldman & Rajesh Balkrishnan. (2012) Medication use and associated health care outcomes and costs for patients with psoriasis in the United States. Journal of Dermatological Treatment 23:3, pages 196-202.
Read now
Read now
Mehdi Amirnia, Effat Khodaeiani, Rohollah Fadaei Fouladi & Ali Hashemi. (2012) Topical steroids versus PUVA therapy in moderate plaque psoriasis: A clinical trial along with cost analysis. Journal of Dermatological Treatment 23:2, pages 109-111.
Read now
Read now
Marc A Radtke, Anna K Langenbruch, Ines Schäfer, Katharina Herberger, Kristian Reich & Matthias Augustin. (2011) Nail psoriasis as a severity indicator: results from the PsoReal study. Patient Related Outcome Measures 2, pages 1-6.
Read now
Read now
A. Brett Hauber, Juan Marcos Gonzalez, Brad Schenkel, Jennifer H. Lofland & Silas Martin. (2011) The value to patients of reducing lesion severity in plaque psoriasis. Journal of Dermatological Treatment 22:5, pages 266-275.
Read now
Read now
Silas Martin, Steven R. Feldman, Matthias Augustin, Philippe Szapary & Brad Schenkel. (2011) Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis. Journal of Dermatological Treatment 22:3, pages 138-143.
Read now
Read now
Articles from other publishers (56)
Meraj Alam, Md. Rizwanullah, Showkat Rasool Mir & Saima Amin. (2023) Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis. OpenNano 10, pages 100123.
Crossref
Crossref
Nikolai Loft, Lone Skov, Craig Richardson, Vivek Trivedi, Ivette Alarcon & Alexander Egeberg. (2022) A nationwide population-based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark. British Journal of Dermatology 187:3, pages 353-363.
Crossref
Crossref
Taylor E. Gladys, Steven Maczuga & Alexandra Flamm. (2021) Characterizing demographics and cost of care for dyshidrotic eczema. Contact Dermatitis 86:2, pages 107-112.
Crossref
Crossref
N. Zander, M. Naatz, M. Augustin, A. Langenbruch, J. Topp, U. Mrowietz, R. von Kiedrowski, M. Krensel, D. Jungen & N. Kirsten. (2020) Determinants of costs and benefits in psoriasis routine care: results from a cross‐sectional nationwide study in Germany. Journal of the European Academy of Dermatology and Venereology 35:1.
Crossref
Crossref
Khoa B. Nguyen, Charlotte Read, Kevin K. Wu & April W. Armstrong. (2020) Where you live matters: Regional differences in health care resource use for psoriasis in the United States. Journal of the American Academy of Dermatology 82:6, pages 1360-1367.
Crossref
Crossref
Kento Mizutani, Eri Shirakami, Masako Ichishi, Yoshiaki Matsushima, Ai Umaoka, Karin Okada, Yukie Yamaguchi, Masatoshi Watanabe, Eishin Morita & Keiichi Yamanaka. (2020) Systemic Dermatitis Model Mice Exhibit Atrophy of Visceral Adipose Tissue and Increase Stromal Cells via Skin-Derived Inflammatory Cytokines. International Journal of Molecular Sciences 21:9, pages 3367.
Crossref
Crossref
María Laura Galimberti, Aldana S. Vacas, Barbara A. Hernández, María L. Bollea Garlatti, María J. Cura & Ricardo L. Galimberti. (2020) Medical resource consumption of moderate/severe psoriasis in a private health organization of Buenos Aires, Argentina. Anais Brasileiros de Dermatologia 95:1, pages 20-24.
Crossref
Crossref
Andrew BlauveltNianwen ShiBaojin ZhuRussel BurgeWilliam N. MalatestinicChen-Yen LinCarolyn R. LewNicole M. ZimmermanOrin M. GoldblumMwangi J. Murage. (2019) Comparison of Health Care Costs Among Patients with Psoriasis Initiating Ixekizumab, Secukinumab, or Adalimumab. Journal of Managed Care & Specialty Pharmacy 25:12, pages 1366-1376.
Crossref
Crossref
C Liu, H Liu, C Lu, J Deng, Y Yan, H Chen, Y Wang, C-L Liang, J Wei, L Han & Z Dai. (2019) Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model. Clinical and Experimental Immunology 198:3, pages 403-415.
Crossref
Crossref
Maosheng Chen, Jing Peng, Qi Xie, Na Xiao, Xian Su, Hua Mei, Yeping Lu, Jia Zhou, Yanni Dai, Siqi Wang, Chuang Li, Ge Lin & Lamei Cheng. (2019) Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs). Stem Cells International 2019, pages 1-13.
Crossref
Crossref
Havva Hilal AYVAZ. (2019) SIK GÖRÜLEN DERMATOLOJİK HASTALIKLARIN EKONOMİK YÜKÜTHE ECONOMIC BURDEN OF COMMON DERMATOLOGICAL DISEASES. ESTÜDAM Halk Sağlığı Dergisi 4, pages 35-51.
Crossref
Crossref
Farzad Alinaghi, Monika Calov, Lars Erik Kristensen, Dafna D. Gladman, Laura C. Coates, Denis Jullien, Alice B. Gottlieb, Paolo Gisondi, Jashin J. Wu, Jacob P. Thyssen & Alexander Egeberg. (2019) Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies. Journal of the American Academy of Dermatology 80:1, pages 251-265.e19.
Crossref
Crossref
Seyed Parham Khalili. 2019. Common Dermatologic Conditions in Primary Care. Common Dermatologic Conditions in Primary Care
139
154
.
Nathaniel HendrixDaniel A. OllendorfRichard H. ChapmanAnne LoosShanshan LiuVarun KumarJeffrey A. LinderSteven D. PearsonDavid L. Veenstra. (2018) Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis. Journal of Managed Care & Specialty Pharmacy 24:12, pages 1210-1217.
Crossref
Crossref
B. Strober, J. Crowley, R.G. Langley, K. Gordon, A. Menter, C. Leonardi, D. Arikan & W.C. Valdecantos. (2018) Systematic review of the real‐world evidence of adalimumab safety in psoriasis registries. Journal of the European Academy of Dermatology and Venereology 32:12, pages 2126-2133.
Crossref
Crossref
Tom Hartwig, Pascale Zwicky, Bettina Schreiner, Nikhil Yawalkar, Phil Cheng, Alexander Navarini, Reinhard Dummer, Lukas Flatz, Curdin Conrad, Christoph Schlapbach & Burkhard Becher. (2018) Regulatory T Cells Restrain Pathogenic T Helper Cells during Skin Inflammation. Cell Reports 25:13, pages 3564-3572.e4.
Crossref
Crossref
M.T. Svendsen, F. Andersen, K.H. Andersen, A. Pottegård, H. Johannessen, S. Möller, B. August, S.R. Feldman & K.E. Andersen. (2018) A smartphone application supporting patients with psoriasis improves adherence to topical treatment: a randomized controlled trial. British Journal of Dermatology 179:5, pages 1062-1071.
Crossref
Crossref
Shinya Kato, Yoshiaki Matsushima, Kento Mizutani, Fumihiro Kawakita, Masashi Fujimoto, Karin Okada, Makoto Kondo, Koji Habe, Hidenori Suzuki, Hitoshi Mizutani & Keiichi Yamanaka. (2018) The Stenosis of Cerebral Arteries and Impaired Brain Glucose Uptake by Long-Lasting Inflammatory Cytokine Release from Dermatitis Is Rescued by Anti-IL-1 Therapy. Journal of Investigative Dermatology 138:10, pages 2280-2283.
Crossref
Crossref
Seina LeeLin XieYuexi WangNeel VaidyaOnur Baser. (2018) Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population. Journal of Managed Care & Specialty Pharmacy 24:7, pages 654-663.
Crossref
Crossref
Dongmun Ha, JeeYeon Lee, Dajeong Kim, In-Sun Oh, Eui-Kyung Lee & Ju-Young Shin. (2018) Healthcare utilization and medical expenditure of Korean psoriasis patients. Medicine 97:24, pages e11070.
Crossref
Crossref
S.L. Klijn, J.M.P.A. van den Reek, G. van de Wetering, A. van der Kolk, E.M.G.J. de Jong & W. Kievit. (2018) Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE. British Journal of Dermatology 178:5, pages 1181-1189.
Crossref
Crossref
D. Jungen, M. Augustin, A. Langenbruch, N. Zander, K. Reich, K. Strömer, D. Thaci, S. Purwins, M. Radtke & M. Gutknecht. (2017) Cost‐of‐illness of psoriasis – results of a German cross‐sectional study. Journal of the European Academy of Dermatology and Venereology 32:1, pages 174-180.
Crossref
Crossref
Douglas Wolf, Martha Skup, Hongbo Yang, Anna P. Fang, Andrew Kageleiry, Jingdong Chao, Manish Mittal & Mark Lebwohl. (2017) Clinical Outcomes Associated with Switching or Discontinuation from Anti-TNF Inhibitors for Nonmedical Reasons. Clinical Therapeutics 39:4, pages 849-862.e6.
Crossref
Crossref
Z.Z.N. Yiu. (2017) Psoriasis and increased drug utilization: a true burden of psoriasis or potential surveillance bias of comorbidities?. British Journal of Dermatology 176:3, pages 566-567.
Crossref
Crossref
E.A. Dowlatshahi, L.M. Hollestein, R.M.C. Herings, T. Nijsten & M. Wakkee. (2017) Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner data. British Journal of Dermatology 176:3, pages 634-642.
Crossref
Crossref
Mayassa J. Bou-Dargham, Zahraa I. Khamis, Armand B. Cognetta & Qing-Xiang Amy Sang. (2017) The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha. Medicinal Research Reviews 37:1, pages 180-216.
Crossref
Crossref
Vibeke Strand, Elaine Husni, Jenny Griffith, Zheng-Yi Zhou, James Signorovitch & Arijit Ganguli. (2016) Economic Evaluation of Timely Versus Delayed Use of Tumor Necrosis Factor Inhibitors for Treatment of Psoriatic Arthritis in the US. Rheumatology and Therapy 3:2, pages 305-322.
Crossref
Crossref
Matthias Augustin & Magdalene Krensel. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
10
.
Dillon Kersh, Roselyn Kellen & Sharon Rose. (2016) The Annual Economic Burden of Psoriasis. Journal of Psoriasis and Psoriatic Arthritis 1:3, pages 112-122.
Crossref
Crossref
Lorenzo Mantovani, Massimo Medaglia, Patrizio Piacentini, Marcella Tricca, Gino Antonio Vena, Antonietta Vozza, Gabriella Castellino & Alessandro Roccia. (2016) Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective. Dermatology and Therapy 6:2, pages 151-167.
Crossref
Crossref
Sofia Löfvendahl, Ingemar F. Petersson, Elke Theander, Åke Svensson, Caddie Zhou & Katarina Steen Carlsson. (2016) Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?. The Journal of Rheumatology 43:3, pages 640-647.
Crossref
Crossref
Nilgün Atakan, Ayça Cordan Yazici, Güzin Özarmağan, Hüseyin Serhat İnalÖz, Mehmet Ali Gürer, İlham Sabuncu, Ümmühan Kİremİtçİ, Sibel Alper, Sema Aytekİn, Özer Arican, Mualla Polat, Sibel Doğan & Emre Aldİnç. (2015)
TUR
‐
PSO
: A cross‐sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey
. The Journal of Dermatology 43:3, pages 298-304.
Crossref
Crossref
Tom Hartwig, Stanislav Pantelyushin, Andrew L. Croxford, Paulina Kulig & Burkhard Becher. (2015) Dermal IL-17-producing γδ T cells establish long-lived memory in the skin. European Journal of Immunology 45:11, pages 3022-3033.
Crossref
Crossref
Steven R. Feldman, Yang Zhao, Lizheng Shi & Mary Helen Tran. (2015) Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. Journal of Managed Care & Specialty Pharmacy 21:10, pages 874-888.
Crossref
Crossref
Caroline P. Schaefer, Joseph C. Cappelleri, Rebecca Cheng, Jason C. Cole, Scott Guenthner, Joseph Fowler, Sandy Johnson & Carla Mamolo. (2015) Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States. Journal of the American Academy of Dermatology 73:4, pages 585-593.e3.
Crossref
Crossref
Jacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, Anshu Shrestha, Alison Sexton, Seth Seabury & Mark Lebwohl. (2015) Evaluating the economic burden of psoriasis in the United States. Journal of the American Academy of Dermatology 72:6, pages 961-967.e5.
Crossref
Crossref
L.-T. Kao, K.-H. Wang, H.-C. Lin, H.-C. Li, S. Yang & S.-D. Chung. (2015) Use of health care services by patients with psoriasis: a population-based study. British Journal of Dermatology 172:5, pages 1346-1352.
Crossref
Crossref
Steven R. Feldman, Yang Zhao, Lizheng Shi, Mary Helen Tran & Jackie Lu. (2015) Economic and Comorbidity Burden Among Moderate‐to‐Severe Psoriasis Patients with Comorbid Psoriatic Arthritis. Arthritis Care & Research 67:5, pages 708-717.
Crossref
Crossref
Wei Zhang, Nazrul Islam, Canice Ma & Aslam H. Anis. (2014) Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis. PharmacoEconomics 33:4, pages 327-340.
Crossref
Crossref
Li-Ting Kao, Cha-Ze Lee, Shih-Ping Liu, Ming-Chieh Tsai & Herng-Ching Lin. (2014) Psoriasis and the Risk of Pneumonia: A Population-Based Study. PLoS ONE 9:12, pages e116077.
Crossref
Crossref
M. Le Moigne, A. Sommet, M. Lapeyre‐Mestre, R. Bourrel, L. Molinier, C. Paul & J‐.L. Montastruc. (2013) Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database. Journal of the European Academy of Dermatology and Venereology 28:9, pages 1235-1244.
Crossref
Crossref
Kuan-Chen Chen, Sheng-Tzu Hung, Ching-Wen Wendy Yang, Tsen-Fang Tsai & Chao-Hsiun Tang. (2014) The economic burden of psoriatic diseases in Taiwan. Journal of Dermatological Science 75:3, pages 183-189.
Crossref
Crossref
Keiichi Yamanaka, Takehisa Nakanishi, Hiromitsu Saito, Junko Maruyama, Kenichi Isoda, Ayumu Yokochi, Kyoko Imanaka-Yoshida, Kenshiro Tsuda, Masato Kakeda, Ryuji Okamoto, Satoshi Fujita, Yoichiro Iwakura, Noboru Suzuki, Masaaki Ito, Kazuo Maruyama, Esteban C. Gabazza, Toshimichi Yoshida, Motomu Shimaoka & Hitoshi Mizutani. (2014) Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases. PLoS ONE 9:8, pages e104479.
Crossref
Crossref
Charles G. Helmick, Hyewon Lee-Han, Shawn C. Hirsch, Tiffany L. Baird & Christopher L. Bartlett. (2014) Prevalence of Psoriasis Among Adults in the U.S.. American Journal of Preventive Medicine 47:1, pages 37-45.
Crossref
Crossref
A. Bewley, D. M. Burrage, S. J. Ersser, M. Hansen & C. Ward. (2013) Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two‐stage qualitative and quantitative study. Journal of the European Academy of Dermatology and Venereology 28:6, pages 763-770.
Crossref
Crossref
F. Maunoury, A. Motrunich, B. Halioua, A. de Fontaubert, Agathe Maury Le Breton, François Dogniaux, ME. Roussel & JF Stalder. (2014) Coûts annuels de prise en charge des patients atteints de psoriasis traités par topiques en France. Journal de gestion et d'économie médicales Vol. 31:7, pages 457-472.
Crossref
Crossref
Baojin Zhu, Emily Edson-Heredia, Jennifer L. Gatz, Jiaying Guo & Catherine L. Shuler. (2013) Treatment Patterns and Health Care Costs for Patients With Psoriatic Arthritis on Biologic Therapy: A Retrospective Cohort Study. Clinical Therapeutics 35:9, pages 1376-1385.
Crossref
Crossref
Reginald Villacorta, Joel W. Hay & Andrew Messali. (2013) Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States. PharmacoEconomics 31:9, pages 823-839.
Crossref
Crossref
Suja E George, Rosaleen J Anderson, Malcolm Haswell & Paul W Groundwater. (2013) An investigation of the effects of dithranol-induced apoptosis in a human keratinocyte cell line. Journal of Pharmacy and Pharmacology 65:4, pages 552-560.
Crossref
Crossref
Georgia Avgerinou, Ioannis Bassukas, Georgios Chaidemenos, Andreas Katsampas, Marita Kosmadaki, Hara Kousoulakou, Athanasios Petridis, Brad Schenkel, Dimitrios Sotiriadis, Theofanis Spiliopoulos, Panagiotis Stavropoulos, Evgenia Toumpi & Loukas Xaplanteris. (2012) Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece. BMC Dermatology 12:1.
Crossref
Crossref
Shelbi C. Jim On & Mark Lebwohl. (2018) Barriers Imposed by Insurance Companies to Biologic Therapy in Patients with Moderate-to-Severe Psoriasis. Psoriasis Forum 18a:4, pages 217-220.
Crossref
Crossref
Giovanna Raho, Daniela Mihajlova Koleva, Livio Garattini & Luigi Naldi. (2012) The Burden of Moderate to Severe Psoriasis. PharmacoEconomics 30:11, pages 1005-1013.
Crossref
Crossref
Gayathri K. PereraPaola Di MeglioFrank O. Nestle. (2012) Psoriasis. Annual Review of Pathology: Mechanisms of Disease 7:1, pages 385-422.
Crossref
Crossref
Nicola Balato, Luisa Di Costanzo, Fabio Ayala, Anna Balato, Alessandro Sanduzzi & Marialuisa Bocchino. (2012) Psoriatic Disease and Tuberculosis Nowadays. Clinical and Developmental Immunology 2012, pages 1-10.
Crossref
Crossref
Kai Li & April W. Armstrong. (2012) A Review of Health Outcomes in Patients with Psoriasis. Dermatologic Clinics 30:1, pages 61-72.
Crossref
Crossref
Frank Bachmann, Georgios Kokolakis, Wolfram Sterry & Sandra Philipp. (2011) Etanercept overview of clinical experience in the treatment of psoriasis and psoriatic arthritis. International Journal of Clinical Rheumatology 6:2, pages 135-155.
Crossref
Crossref